List of Attending Speakers | 2024
- Jeremy Caldwell, Parner, Red Tree Venture Capital
- Mira Chaurushiya, Managing Director, Westlake Village BioPartners
- John Connolly, Chief Scientific Officer, Parker Institute for Cancer Immunology; Iterim CEO, 3T Biosciences
- Neel Desai, Business Development & Licensing, Biogen
- Karen Deschaine, Partner, Wilson Sonsini Goodrich & Rosati
- Richard DiMarchi, Professor, Indiana University
- Dalton Einhorn, Global Head of Pharmaceutical Corporate Venture Capital, Asahi Kasei Pharma
- Dan Estes, General Partner, Frazier Life Sciences
- Simone Fishburn, Vice President and Editor in Chief, BioCentury Inc.
- William Haddad, Partner, Venable LLP
- Richard Heyman, Venture Partner, Arch Ventures
- Andrea Houghton, VP Global Head of Biology, Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson
- Albert Hwang, Managing Director, Head of US Healthcare Investment Banking, Morgan Stanley
- Kim Kamdar, Partner, Medical Excellence Capital
- Rachna Khosla, Senior Vice President, Business Development, Amgen
- Jim Krenn, Partner, Morrison & Foerster
- Jennifer Leeds, Executive Director, Head BD&L Search and Evaluation, West Coast and Canada, Translational Medicine, and Oncology at Novartis
- John Lepore, CEO, ProFound Therapeutics; CEO-Partner, Flagship Pioneering
- Nan Li, Founder and Managing Partner, Dimension
- Jay Lichter, Managing Partner, Avalon Ventures
- Stuart Mackey, Global Head of Business Development, Daiichi Sankyo
- Mathai Mammen, CEO, President and Chairman, FogPharma
- Konstantina Manjoros Katcheves, Senior Vice President Business Development, Bristol Myers Squibb
- Peter Meinke, Sanders Director, Tri-Institutional Therapeutics Discovery Institute, Inc’
- Detlev Mennerich, Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim
- Mitchell Mutz, Entrepenuer Partner, Vivo Capital
- Imran Nasrullah, Vice President & Head, Collaborate to Cure Hub US, Business Development & Licensing at Bayer Pharmaceuticals, Bayer
- Carolyn Ng, Partner and Managing Director, TPG Life Sciences Innovations
- Carole Nuechterlein, Head, Roche Venture Fund
- Daniel Parisotto, Managing Director, Healthcare Banking, Oppenheimer
- Emma Parmee, Global Head Therapeutics Discovery, The Janssen Pharmaceutical Companies of Johnson and Johnson
- Sunil Patel, Head of Corporate Development and Business Development & Licensing, Merck
- Danjuma Quarless, Associate Director, AbbVie Ventures
- Jeremy Quirk, VP BD&L Commercial Portfolio, GSK
- Visali Ramanathan, Senior Director, Business Development, Genentech
- Brad Robling, Vice President, Lilly Ventures, Eli Lilly & Company
- Christalyn Rhodes, Associate Vice President, Genetic Medicine, External Partnerships and Collaborations, Eli Lilli and Company
- Camille Samuels, Partner, Venrock
- Peter Schultz, Scripps Family Chair Professor, President and CEO, Department of Chemistry, Scripps Research
- Andy Schwab, Founder & Managing Partner, 5AM Ventures
- Ben Sklaroff, CTo, Co-Founder, Genesis Therapeutics
- Marshall Smith, Global Head of the Healthcare Group, Investment Banking Division, Goldman Sachs
- Uwe Schoenbeck, Venture Partner, Cannan
- Jay Stamatis, Vice President, Head of Business Development and Acquisitions, AbbVie
- Tari Suprapto, Director, Search & Evaluation (West), Novo Nordisk
- Philip Tagari, CSO, Insitro
- Nancy Thornberry, Founding CEO and Chair, R&D, Kallyope
- Daniel Tumas, VP, Search and Evaluation, Corporate Development, Gilead Sciences
- Court Turner, Partner, LYZZ Capital Advisors
- D.A. Wallach, General Partner, Co-Founder, Time BioVentures
- Michael Weingarten, Director of the Small Business Innovation Research Development Center, NCI SBIR Development Center
- Charity Williams, Partner, Cooley
- Asish Xavier, J&J Innovation, JJDC Vice President, Venture Investments, Johnson & Johnson